ArticleCancer research2017

SFK/FAK Signaling Attenuates Osimertinib Efficacy in Both Drug-Sensitive and Drug-Resistant Models of EGFR-Mutant Lung Cancer.

Eiki Ichihara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.